Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris. [electronic resource]
Producer: 20150921Description: 244-52 p. digitalISSN:- 1365-2133
- Adalimumab
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Biological Factors -- therapeutic use
- Dermatologic Agents -- therapeutic use
- Drug Substitution
- Etanercept
- Female
- Humans
- Immunoglobulin G -- therapeutic use
- Infliximab
- Male
- Prospective Studies
- Psoriasis -- drug therapy
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Treatment Outcome
- Ustekinumab
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.